Thermo Fisher Scientific (China): difference between revisions
Diff·revision 16 → 17·18:00, 26 Jul 2026
Difference between revision 16 and revision 17 of Thermo Fisher Scientific (China). 3 lines changed; the page grew by 1,205 bytes.
| Revision 16 — 18:00, 26 Jul 2026 WeaselWordWim (talk) attribute the documentation description to the purchaser reports it comes from 12,000 bytes +621 | Revision 17 — 18:00, 26 Jul 2026 PrimarySrcPatia (talk) space between number and unit per PP:MOS 13,205 bytes +1,205 | ||
|---|---|---|---|
| 65 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 65 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 66 | 66 | ||
| + | 67 | == Reception == | |
| + | 68 | The PeptidePedia tally records 738 self-reported submissions concerning TFS to August 2026. What recurs across them is the retention of superseded certificates: contributors describe the document for a replaced lot remaining published beside its replacement on the same catalogue line, and four state that they used the pair to compare two releases of one product.{{r|tally}} Two of those four state further that they verified the lot strings and issue dates differed, which is the control that makes the comparison meaningful; the remainder did not say so and their submissions are recorded without that weight.{{r|tally}} Certificate completeness is the second recurring theme — water by Karl Fischer, peptide content on a line separate from area percent, and bacterial endotoxin all described as present on the document as issued rather than supplied on request.{{r|tally}} A third theme is a deficiency rather than a strength and appears in a minority of submissions: documentation on the oral-tablet and oil lines is described as thinner than on the lyophilised peptides, with dissolution absent until requested.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | |
| + | 69 | ||
| 67 | == References == | 70 | == References == |
| 68 | {{reflist}} | 71 | {{reflist}} |